Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: MYRIO THERAPEUTICS PTY LTD
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-02-01 to 2024-04-01
Current total value of award: $51836
Description: BISPECIFIC ANTIBODIES AGAINST CT-RCC HERV-E